Search results
The four partners who led the Index Ventures life sciences practice are the founding partners of medicxi and will constitute its executive management team: Francesco De Rubertis, David Grainger, Kevin Johnson and Michèle Ollier.
Francesco is a co-founder and Partner at Medicxi. Prior to Medicxi, Francesco was a Partner at Index Ventures for 19 years, having joined the firm in 1997 to launch its life sciences practice. Under his leadership, the asset-centric approach to life sciences investing was conceived and implemented.
Oct 5, 2020 · If you are looking to eat at the top pizzeria in the world, rated by the prestigious ‘ 50 Top Pizza ‘ in 2020 for the second year in a row, I Masanielli Pizzeria da Francesco Martucci is the place for you.
Apr 8, 2024 · Francesco De Rubertis, Partner at Medicxi, will join the Board of D3 Bio. D3 Bio has built a pipeline of multiple oncology assets, all with first-in-class or best-in-class potential and foundational properties targeting immune-pathways or tumour driving mutations.
The whole thing is topped with De Masi's melodic score and a stirring vocal by Raul Lovecchio. (Like many songs from Italian westerns, the phonetically-sung lyrics are mainly indecipherable.) Here's a suite:
Dr. Francesco De Rubertis is Chairman of the Board at Centessa Pharmaceuticals and a co-founder and partner at Medicxi. Prior to Medicxi, Francesco was a partner at Index Ventures for 19 years, having joined the firm in 1997 to launch its life sciences practice.
Dec 5, 2019 · Original publisher: Nazionalmusic (SIAE) - Diesis (SIAE) Sigla PEA: Jingle composed by Francesco de Masi. trademark of PEA Film Distribution. View credits, reviews, tracks and shop for the 2019 CD release of "Il Segno Del Coyote" on Discogs.
